Gabriela Berlakovich completed her Doctoral degree and following her Fellowship and Residency at the Medical University of Vienna (MUW). During her training in surgery she visited as Clinical Fellow the Department of Surgery, University of California Los Angeles (UCLA), the Department of Hepatobiliary Surgery and Transplantation, University Hospital Eppendorf (Hamburg), and the Department of Transplantation and Immunology, Kyoto University.
Dr. Berlakovich is Board-certified in Visceral Surgery, Intensive Care Medicine, and Vascular Surgery. Her academic appointments were Associate Professor of Surgery at MUW (1999), and her actual academic and clinical position is Head of the Department of Transplantation at MUW (since 2017).
During her academic career Dr. Berlakovich received numerous scientific honors and awards as achievements in scientific societies. She served as Board Member of the European Liver and Intestine Transplantation Association (ELITA), was Member of the Steering Committee and Board Member of Women in Transplantation (WIT). Actually she is Board Member of the Austrian Society for Transplantation, Transfusion und Genetics (Austrotransplant), Council Member of the International Liver Transplantation Society (ILTS), Affiliated Councilor of the Equality, Diversity & Inclusion Committee (EDI-ILTS), Member of the Examining Boards of the UEMS, Member of ÖBIG-Advisory Board Transplant (Austrian Federal Institute of Health) and elected Board Member A of Eurotransplant, the largest European OPO. Her scientific interest is clinical liver transplantation focusing on alcoholic cirrhosis,hepatocellular carcinoma and immunology. Actually Dr. Berlakovich established successfully a liver machine perfusion program in the Transplant Center Vienna. Additional scientific projects include new approaches for liver allocation and increasing organ donation.
Dr. Berlakovich published numerous peer-reviewed original articles, several book chapters and is frequently invited as chair or keynote speaker to scientific conferences.